A thiazolidinedione for hepatitis B
Thiazolidinediones may hold the key to developing a new class of anti-HBV medicines that will cure the chronic infection.
Oral Antihyperglycaemics for COPD exacerbations
Emerging evidence is pointing to the benefits of ‘novel’ antihyperglycaemics on lung function in COPD patients.
The toxic history of Thallium
After its discovery, thallium quickly became one of the most dangerous poisons — used in pesticides, medicine and fictional murders alike.
Children’s vaccinations
In recent years jurisdictional regulations have been amended enabling Australian pharmacists to administer some vaccines to children.
Keeping lifetime OCS below 1,000 mg
Every course of OCS, either in long-term administration or repetitive bursts – takes people closer to a total lifetime dose of OCS, which is dangerous.
Pharmacy’s neuro-affirming approach to autism
By adopting neuro-affirming approaches pharmacists can reduce barriers to deliver more personalised care to autistic individuals.













